Skip to main content

Table 2 Characteristics related to the overall mortality of patients with heart failure at New York heart Association IV functional class, according to gender

From: Relationship between the place of living and mortality in patients with advanced heart failure

 

Overall

Women

Men

Alive

N = 556

Dead

N = 592

P value

Alive

N = 371

Dead

N = 337

P value

Alive

N = 185

Dead

N = 255

P value

Age

79.7 (9.3)

83.3 (8.0)

< 0.001

81.4 (8.6)

85.0 (7.7)

< 0.001

76.5 (9.9)

81.2 (7.7)

< 0.001

Body Mass Index

31.5 (6.7)

28.9 (6.4)

< 0.001

32.4 (6.8)

30.1 (7.0)

< 0.001

30.0 (6.2)

27.5 (5.2)

< 0.001

Smoker

22 (4)

19 (3)

0.698

7 (2)

1 (0)

0.112

15 (8)

18 (7)

0.009

Comorbidity

 Diabetes

234 (42)

251 (42)

0.971

154 (41)

132 (39)

0.577

80 (43)

119 (47)

0.538

 Coronary heart disease

178 (32)

197 (33)

0.782

100 (27)

84 (25)

0.597

78 (42)

113 (44)

0.725

 Stroke

78 (14)

85 (14)

0.854

50 (14)

41 (12)

0.683

28 (15)

44 (17)

0.644

 Chronic kidney disease

162 (29)

229 (39)

< 0.001

119 (32)

134 (40)

0.040

43 (23)

95 (37)

0.003

 Chronic obstructive pulmonary disease

170 (31)

208 (35)

0.089

76 (21)

69 (21)

1.000

94 (51)

139 (55)

0.502

 Atrial fibrillation

254 (46)

282 (48)

0.707

184 (50)

172 (51)

0.758

70 (38)

110 (43)

0.309

 Cancer

81 (15)

135 (23)

< 0.001

54 (15)

60 (18)

0.284

27 (15)

75 (29)

< 0.001

 Hypertension

449 (81)

460 (77)

0.218

313 (84)

281 (83)

0.800

136 (74)

179 (70)

0.513

Clinical Variables

 Heart Rate (beats/minute) a

76.6 (15.2)

76.8 (14.0)

0.735

76.7 (15.4)

76.5 (14.3)

0.798

76.4 (14.9)

77.4 (13.7)

0.487

 Systolic blood pressure (mmHg)a

127.7 (18.4)

123.3 (18.5)

< 0.001

129 (18.3)

125 (19.2)

0.007

126 (18.4)

121 (17.5)

0.009

 Diastolic blood pressure (mmHg)a

69.5 (10.7)

66.7 (10.3)

< 0.001

70.2 (11.1)

67.1 (10.3)

< 0.001

68.2 (9.8)

66.3 (10.4)

0.051

 Potassium mEq/L a

4.5 (0.5)

4.6 (0.6)

0.033

4.4 (0.5)

4.5 (0.5)

0.133

4.5 (0.6)

4.6 (0.6)

0.370

 Sodium mEq/L a

140.8 (3.5)

140.5 (3.9)

0.060

141 (3.4)

141 (3.7)

0.351

141 (3.5)

140 (3.9)

0.309

 Glomerular filtration

1.2 (0.6)

1.4 (0.8)

< 0.001

1.1 (0.4)

1.3 (0.5)

< 0.001

1.3 (0.8)

1.5 (1.0)

0.007

 Hemoglobin (g/dL)a

12.3 (1.7)

11.9 (1.8)

< 0.001

12.2 (1.5)

11.7 (1.7)

< 0.001

12.8 (1.9)

12.3 (1.9)

0.009

 Barthel Index a

59.8 (27.8)

54.4 (28.6)

< 0.001

55.9 (27.2)

48.5 (27.6)

< 0.001

67.8 (27.5)

62.4 (28.2)

0.043

 Charlson Index a

3.2 (1.6)

3.8 (1.8)

< 0.001

3.2 (1.5)

3.5 (1.6)

0.024

3.4 (1.6)

4.2 (1.9)

< 0.001

Medication

 Beta-blockers

271 (49)

246 (42)

0.011

182 (49)

143 (42)

0.091

89 (48)

103 (40)

0.130

 ACEi or ARB b

397 (71)

361 (61)

< 0.001

262 (71)

216 (64)

0.077

135 (73)

145 (56)

0.001

 MRAc

145 (26)

159 (27)

0.883

83 (22)

79 (23)

0.803

62 (33)

80 (31)

0.711

 Loop diuretics

479 (86)

536 (91)

0.083

315 (85)

306 (91)

0.023

164 (89)

230 (90)

0.714

Social Variables

 Living alone

164 (29)

179 (30)

0.988

121 (33)

100 (30)

0.446

43 (23)

79 (31)

0.093

 Inadequate housing conditions

220 (40)

287 (48)

0.002

131 (35)

166 (49)

< 0.001

89 (48)

121 (47)

0.968

  1. aMean (Standard deviation); bACEi angiotensin converting enzyme inhibitors, ARB Angiotensin II receptor blockers);cMRA mineralocorticoid receptor antagonists